FDA Inspection
Liberty Pharma Inc.Liberty Pharma Inc. – FDA Inspection, Dec 9, 2016
Record Details
This FDA Inspection record concerns Liberty Pharma Inc., with an inspection on December 9, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- Rita K. Vick (Issuing Officer)
View Company Profile
ID · e02a1ec3-a4f0-4a2a-bd72-c067e4b2cd68
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 993871
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.100(b)SOPs not followed / documented
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Liberty Pharma Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 17, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Liberty Pharma Inc.
- FDA Inspection 1173396 - 2022-06-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.